Seeking Alpha

Codexis (CDXS) +8.5% premarket after announcing the FDA approved a new process it co-developed...

Codexis (CDXS) +8.5% premarket after announcing the FDA approved a new process it co-developed for manufacturing sitagliptin, the active pharmaceutical ingredient in Merck's (MRK) Januvia diabetes drug.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)